MYL-1402O: A Bevacizumab Biosimilar (vol 17, pg 85, 2022)

Lee, A

Lee, A (通讯作者),Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

TARGETED ONCOLOGY, 2022; 17 (3): 379